3 completed, 3 recruiting, 2 terminated, 2 unknown. 11 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 3, Recruiting 3, Terminated 2, Unknown 2, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Fetal Death: new trials by email Literature Review of Fetal Death trials Research Report on Fetal Death
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Dexmedetomidine to Reduce Post-procedure Grief Following Second-trimester Dilation and Evacuation Dexmedetomidine (IV) 0.5 mcg/kg, Placebo - Abortion, Stillbirth | Phase 2 / Phase 3 | Withdrawn | Stanford University | 2026-07-01 | 2026-07-17 | |
| Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries Oral nitrofurantoin monohydrate/macrocrystals, Placebo - Preterm Birth, Small for Gestational Age (SGA) | Phase 3 | Recruiting | NICHD Global Network for Women's and Children's Health | 1134 | 2025-12-08 | 2026-01-22 |
| Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial 162mg Aspirin, 81mg Aspirin - Preterm Delivery, Obstetrical Complications | Phase 3 | Recruiting | The George Washington University Biostatistics Center | 1800 | 2025-07-01 | 2026-04-09 |
| Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction Placebo, Melatonin 10 MG - Fetal Growth Retardation, Stillbirth and Fetal Death | Phase 3 | Recruiting | Monash University | 336 | 2019-05-29 | 2025-06-06 |
| A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders Docosahexaenoic acid (DHA), Placebo (for Docosahexaenoic acid (DHA)) - Premature Birth, Preeclampsia | Phase 3 | Unknown | Pontificia Universidad Catolica de Chile | 2400 | 2015-05-01 | 2015-11-04 |
| Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death Mifepristone, Placebo, Misoprostol 200mcg - Fetal Death | Phase 3 | Terminated | Gynuity Health Projects | 200 | 2015-04-01 | 2019-02-11 |
| Low Dose Aspirin for the Prevention of Preeclampsia Aspirin, Placebo - Preeclampsia | Phase 3 | Unknown | Saint Thomas Hospital, Panama | 476 | 2013-07-01 | 2013-07-01 |
| Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy Misoprostol - Intrauterine Fetal Demise | Phase 3 | Completed | Gynuity Health Projects | 153 | 2008-10-01 | 2013-05-08 |
| Impact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality folic acid, folic acid plus iron, supplements with multiple vitamins and minerals - Perinatal Mortality, Stillbirth | Phase 3 | Completed | Centers for Disease Control and Prevention | 18962 | 2006-05-01 | 2011-03-21 |
| A Randomized Trial of Two Regimens of Misoprostol for Second Trimester Termination for Intrauterine Fetal Death Misoprostol - Labor Induction | Phase 3 | Terminated | American University of Beirut Medical Center | 73 | 2004-09-01 | 2013-07-19 |
| Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion Aspirin, Klexane, Klexane and ASA - Habitual Abortion | Phase 3 | Completed | University of Helsinki | 220 | 2002-01-01 | 2009-08-14 |
Stillbirth (10) · Premature Birth (5) · Fetal Growth Retardation (3) · Pre-Eclampsia (3) · Perinatal Death (2) · Abortion, Habitual (1) · Abortion, Spontaneous (1) · Abruptio Placentae (1) · Anemia (1) · Bacteriuria (1) · Birth Weight (1) · Prolonged Grief Disorder (1) · Stress Disorders, Post-Traumatic (1) · Thrombophilia (1)
Death (11) · Female Urogenital Diseases and Pregnancy Complications (11) · Pathologic Processes (11) · Pathological Conditions, Signs and Symptoms (11) · Pregnancy Complications (11) · Urogenital Diseases (11) · Obstetric Labor Complications (6) · Obstetric Labor, Premature (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Fetal Diseases (3) · Growth Disorders (3) · Hypertension, Pregnancy-Induced (3) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2)
Aspirin (3) · Misoprostol (3) · Dexmedetomidine (1) · Docosahexaenoic Acids (1) · Folic Acid (1) · Geritol (1) · Iron (1) · Melatonin (1) · Mifepristone (1) · Minerals (1) · Nitrofurantoin (1)
Gynuity Health Projects (2) · American University of Beirut Medical Center (1) · Centers for Disease Control and Prevention (1) · Monash University (1) · NICHD Global Network for Women's and Children's Health (1) · Pontificia Universidad Catolica de Chile (1) · Saint Thomas Hospital, Panama (1) · Stanford University (1) · The George Washington University Biostatistics Center (1) · University of Helsinki (1)
United States (3) · Vietnam (2) · Australia (1) · Bangladesh (1) · Chile (1) · China (1) · Democratic Republic of the Congo (1) · Finland (1) · Guatemala (1) · India (1) · Lebanon (1) · Mexico (1) · New Zealand (1) · Pakistan (1) · Panama (1)
Ameth Hawkins, MD (1) · Ana Moreno, MD (1) · Anwar H Nassar, MD (1) · Beverly Winikoff, MD, MPH (1) · Cande Ananth, PhD, MPH (1) · Christian Figueroa, MD (1) · Claudio Vera, MSc (1) · Hillary Bracken, PhD (1) · Janvier Visser, MD (1) · Jianmeng Liu, MD, PhD (1) · Jorge Carvajal, PhD (1) · Katja Lampinen, MD (1) · Kirsten Palmer, PhD (1) · Kitty Bloemenkamp, MD (1) · Laure Morin-Papunen, MD (1)
PMID 23303315, PMID 27263403, PMID 29428785, PMID 32358837, PMID 33594802, PMID 34061352, PMID 35265334, PMID 42025271
U01HD109332 (1), U24HD036801 (1)